SlideShare a Scribd company logo
1 of 1
Download to read offline
QQ
AQQ
Gabriel Gherman Bendavit
Department of Biology
Concordia University
In the secretion pathway, TRAPP I located in the Cis
Golgi) interacts with COPII coated vesicles in the ER-cis
Golgi pathway. TRAPP II is located in the trans-Golgi and
tether COP I coated vesicles from the early endosome1.
Vesicle coated proteins (COP I, COPII and Clathrin) act
in vesicle specificity.
TRAPP relevance and role in the secretion pathway
Introduction
TRAPP structure and role in the secretion pathway
Screening Methods Results
Role of TRS23 C terminal from a GEF Ypt/Rab
GTPase study
Workflow of the experiment
Yeast transformation
Mutated TRS23 With High Copy Plasmid Screen status
Acknowledgments
Mutant strain
Supression of mutant Phenotype
Conclusion
CIN 5 selection
The trs23Δ99C haploid S.Cerevisiae (MSY441b
strain type α) was transformed by a high copy
plasmid (Yep 24) with fragments of a high copy
plasmid yeast genomic library (6000 genes) which
generated 36000 colonies . The thermic sensitivity
phenotype (slow growth at 160C) was suppressed in
37 colonies. A positive control was used with another
high copy plasmid (prs 426) with TRS 23 gene on it.
Also, a negative control (prs 426 without yeast
genomic fragment) was used.
Slow growth
at 160C (severe)
After yeast transformation, colonies were replica
plated in three temperatures, permissive (300C),
hot (380C) and cold (160C). Using suppression
of thermic sensitivity phenotype, 15 colonies
were selected to be sequenced.
The role of CIN 5 as the agent suppressor of the mutant
phenotype is so far not conclusive. Its selection was
based in the relationship between TRS 23 and
Chromosome instability described by Ben-Aroya 2008.
In order to follow up on the study, CIN 5 needs to be
isolated and transformed into the trs23Δ99C mutant
yeast.
The activated form of Ypt/Rab is
when (GTP) is bound to Ypt/Rab
and its deactivated form is when
(GDP) is bound. The elements
with GEF activity work by
increasing the phosphorylation
speed of Ypt/Rab GDP and
phosphorylation to its activated
form Ypt/Rab GTP. Both
TRAPPI/II are GEF for Ypt/Rab
GTP ase.
Dr. Michael Sacher and all the great scientists
from his laboratory, especially to Stephanie
Brunet.
Confirmation of CIN5 suppression was done by
digesting this gene from Yep 24 with Eco R1 and
Xho1. The insert was then ligated into the vector
prs 426. After bacteria and yeast transformation,
the colonies will be evaluated for mutant phenotype
suppression. Unfortunately no growth after bacteria
transformation was obtained yet.
The 37 colonies with mutant phenotype
suppressed , selected from the 36,000
transformed yeast colonies, were transformed
into E coli (to increase number of copies). The
plasmids were then transformed back to yeast
(MSY441b) to reevaluate suppression of the
phenotype. A selected gene was used in a new
round of the screening ( digested from Yep24
and ligated in a new plasmid (prs 426 without
TRS23).
Slow growth
at 380C (mild)
After PCR amplification, 15 colonies with
mutant suppressed phenotype were sent to
be sequenced in three different batches.
The six samples that came back as empty
vectors will be transformed back into yeast.
One failed to be sequenced and an other
showed no ORFs. The seven samples with
yeast fragments summed a total of 21
genes. From those, CIN5 from
Chromosome XV was selected.
Membrane trafficking between enclosed cellular compartments
use vesicle-mediated transport in order to deliver secretory
proteins. One of the components involved in cargo selectivity
and proper fusion of vesicles with its specific target membrane
are multi-subunit complexes called tethering factors. The
transport protein particle (TRAPP) complex is a tethering factor
conserved from yeast to man that exists in two types TRAPP I,
in the cis Golgi and TRAPP II, in the trans Golgi . TRAPP I has
seven subunits and TRAPPII has three extra subunits, they
tether COPII and COPI coated protein respectively.2 In yeast
both TRAPPI/II are guanine nucleotide exchange factors (GEF)
for Ypt1/Rab GTPase which activates it. Ypt1/Rab is
responsible for vesicle formation, motility, tethering and fusion
of vesicles1. The TRAPP I subunit TRS 23 is a centrally
localized essential subunit which is a GEF for YPT1/ RAB
GTPase. A study with a C terminal mutated TRS 23 raised
some questions regarding this subunit interactions with the
TRAPPI complex.
Full understanding of TRS 23 function, such as GEF activity for
YPT1/ RAB GTPase, is fundamental for the study of the
mechanisms involved with the secretion pathway. For this
reason a high copy screening of the trs23Δ99C was done.
In a previous study3 a triple mutation on C terminal of TRS
23 was found to be deleterious for the cell with a reduction
of GEF activity in vitro.
TRAPP I complex subunit TRS 23
is centrally localized and
together with Bet 5 have a
binding site, showed by crystal
structure, for Ypt/Rab.
However, when a complete C
terminal deletion was done at
Dr Sacher’s laboratory the cell
was still viable. Also, a
destabilization in the TRAPP I
complex was revealed.
This mutation presented
thermic sensitivity and this
mutant phenotype was used
for the screen of Trs23Δ99C .
After bacteria transformation by heat shocking or
electroporation, the plasmids were extracted and
transformed back to yeast for confirmation of
mutant phenotype suppression.
CIN 5 (from the chromosome XV) encodes for
chromosome instability(CIN) and also salt and
antibiotic resistance.
The CIN 5 selection was based in the association of
TRS 23 with CIN. In one study TRS 23 was
identified by a screening that used a temperature-
sensitive allele for each essential gene in S.
cerevisiae. The mutant TRS 23 showed CIN4.
CIN 5 Ligation
References
Spondyloepiphyseal dysplasia tarda (SEDT) is one
example of TRAPP importance for human health. This
musculoskeletal disorder is associated with TRAPP
subunits of its mammalian homolog TRAPPC2.
The SNARE complex is
responsible for vesicle docking by
interaction of two of its subunits
t SNARE (in the membrane) and v
SNARE ( in the vesicle ). TRAPP I
subunit Bet3 binds to the COPII
subunit Sec 23 allowing t SNARE
and v SNARE to interact1.
1-Sacher M. 2008. Traffic /2- Stephanie Brunet poster 2010 / 3- The cell, fifth edition,chapter 10, figure 10.35 /4-Ben-Aroya 2008,cell
Ref. 3Ref. 3
A high copy number screen of the trs23Δ99C mutant
Ref 2
C terminus
deletion
Triple
mutation
Cells were
still viable
P X
Reduces
GEF activity
P P
Destabilize
d TRAPPI
P NA
XV

More Related Content

What's hot

Taxol and 10-deacetylbaccatinIII induce distinct changes
Taxol and 10-deacetylbaccatinIII induce distinct changesTaxol and 10-deacetylbaccatinIII induce distinct changes
Taxol and 10-deacetylbaccatinIII induce distinct changesNeesar Ahmed
 
Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...Saurabh Shekhar
 
3.24.2010
3.24.20103.24.2010
3.24.2010Greg
 
2014 - cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
2014 - cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation2014 - cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
2014 - cIAP1 regulates TNF-mediated cdc42 activation and filopodia formationSimon Gemble
 
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...James Silverman
 
2004 paper primer ctx dissemination of ctx m-type -lactamases among clinical ...
2004 paper primer ctx dissemination of ctx m-type -lactamases among clinical ...2004 paper primer ctx dissemination of ctx m-type -lactamases among clinical ...
2004 paper primer ctx dissemination of ctx m-type -lactamases among clinical ...JairAlexanderTllez
 
NAGLU_IGF2 in vitro studies
NAGLU_IGF2 in vitro studiesNAGLU_IGF2 in vitro studies
NAGLU_IGF2 in vitro studiesShih-hsin Kan
 
Study of psymberin's mode of action using forward genetics
Study of psymberin's mode of action using forward geneticsStudy of psymberin's mode of action using forward genetics
Study of psymberin's mode of action using forward geneticsVincent Tsao
 
Activation of rat alveolar macrophage derived latent transforming growth fact...
Activation of rat alveolar macrophage derived latent transforming growth fact...Activation of rat alveolar macrophage derived latent transforming growth fact...
Activation of rat alveolar macrophage derived latent transforming growth fact...Tiensae Teshome
 
TCD Results & Thesis
TCD Results & ThesisTCD Results & Thesis
TCD Results & ThesisJames Britton
 
AACR poster VP_2014
AACR poster VP_2014AACR poster VP_2014
AACR poster VP_2014Victor Prima
 
J. Biol. Chem.-2015-Williamson-jbc.M115.640367
J. Biol. Chem.-2015-Williamson-jbc.M115.640367J. Biol. Chem.-2015-Williamson-jbc.M115.640367
J. Biol. Chem.-2015-Williamson-jbc.M115.640367Christopher Cowell
 
Arelis ChlamyPoster_v4
Arelis ChlamyPoster_v4Arelis ChlamyPoster_v4
Arelis ChlamyPoster_v4Arelis Joa
 

What's hot (20)

Taxol and 10-deacetylbaccatinIII induce distinct changes
Taxol and 10-deacetylbaccatinIII induce distinct changesTaxol and 10-deacetylbaccatinIII induce distinct changes
Taxol and 10-deacetylbaccatinIII induce distinct changes
 
Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...
 
nihms557954
nihms557954nihms557954
nihms557954
 
3.24.2010
3.24.20103.24.2010
3.24.2010
 
2014 - cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
2014 - cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation2014 - cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
2014 - cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
 
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
Temp-Sensitive Inhibition of Development in Dictyostelium - Dev Bio 251 18-26...
 
CMBDictyPaper
CMBDictyPaperCMBDictyPaper
CMBDictyPaper
 
Gene expression on rat1 fibroblast cells after transformation by evi1
Gene expression on rat1 fibroblast cells after transformation by evi1Gene expression on rat1 fibroblast cells after transformation by evi1
Gene expression on rat1 fibroblast cells after transformation by evi1
 
2004 paper primer ctx dissemination of ctx m-type -lactamases among clinical ...
2004 paper primer ctx dissemination of ctx m-type -lactamases among clinical ...2004 paper primer ctx dissemination of ctx m-type -lactamases among clinical ...
2004 paper primer ctx dissemination of ctx m-type -lactamases among clinical ...
 
ganzyme PDF.pdf
ganzyme PDF.pdfganzyme PDF.pdf
ganzyme PDF.pdf
 
NAGLU_IGF2 in vitro studies
NAGLU_IGF2 in vitro studiesNAGLU_IGF2 in vitro studies
NAGLU_IGF2 in vitro studies
 
Study of psymberin's mode of action using forward genetics
Study of psymberin's mode of action using forward geneticsStudy of psymberin's mode of action using forward genetics
Study of psymberin's mode of action using forward genetics
 
Activation of rat alveolar macrophage derived latent transforming growth fact...
Activation of rat alveolar macrophage derived latent transforming growth fact...Activation of rat alveolar macrophage derived latent transforming growth fact...
Activation of rat alveolar macrophage derived latent transforming growth fact...
 
TCD Results & Thesis
TCD Results & ThesisTCD Results & Thesis
TCD Results & Thesis
 
Tiggrin
TiggrinTiggrin
Tiggrin
 
AACR poster VP_2014
AACR poster VP_2014AACR poster VP_2014
AACR poster VP_2014
 
14.cell cycle- B - cell biology
14.cell cycle- B - cell biology14.cell cycle- B - cell biology
14.cell cycle- B - cell biology
 
J. Biol. Chem.-2015-Williamson-jbc.M115.640367
J. Biol. Chem.-2015-Williamson-jbc.M115.640367J. Biol. Chem.-2015-Williamson-jbc.M115.640367
J. Biol. Chem.-2015-Williamson-jbc.M115.640367
 
ATM
ATM ATM
ATM
 
Arelis ChlamyPoster_v4
Arelis ChlamyPoster_v4Arelis ChlamyPoster_v4
Arelis ChlamyPoster_v4
 

Similar to A high copy number screen of the trs23Δ99C mutant

Senior Thesis-Analyzing the interactions between MYOGEF and a component of er...
Senior Thesis-Analyzing the interactions between MYOGEF and a component of er...Senior Thesis-Analyzing the interactions between MYOGEF and a component of er...
Senior Thesis-Analyzing the interactions between MYOGEF and a component of er...Dougan McGrath
 
Cancer Res-2014-Chakraborty-3489-500
Cancer Res-2014-Chakraborty-3489-500Cancer Res-2014-Chakraborty-3489-500
Cancer Res-2014-Chakraborty-3489-500Rachel Stupay
 
Altering_Phenylalanine_67_Serine
Altering_Phenylalanine_67_SerineAltering_Phenylalanine_67_Serine
Altering_Phenylalanine_67_SerineAmber Anger
 
Schindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASSchindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASAdam Schindler
 
Venters Molecular and Cellular Biology 2011 2253-2261
Venters Molecular and Cellular Biology 2011 2253-2261Venters Molecular and Cellular Biology 2011 2253-2261
Venters Molecular and Cellular Biology 2011 2253-2261Jordan Irvin
 
Chloroplast transformation
Chloroplast transformationChloroplast transformation
Chloroplast transformationshahnam azizi
 
Poster Presentation Template
Poster Presentation TemplatePoster Presentation Template
Poster Presentation TemplateGeorges Rizk
 
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...Mark Lipstein
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...JohnJulie1
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...NainaAnon
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...daranisaha
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...eshaasini
 

Similar to A high copy number screen of the trs23Δ99C mutant (20)

Senior Thesis-Analyzing the interactions between MYOGEF and a component of er...
Senior Thesis-Analyzing the interactions between MYOGEF and a component of er...Senior Thesis-Analyzing the interactions between MYOGEF and a component of er...
Senior Thesis-Analyzing the interactions between MYOGEF and a component of er...
 
FinalLabReport
FinalLabReportFinalLabReport
FinalLabReport
 
Cancer Res-2014-Chakraborty-3489-500
Cancer Res-2014-Chakraborty-3489-500Cancer Res-2014-Chakraborty-3489-500
Cancer Res-2014-Chakraborty-3489-500
 
Altering_Phenylalanine_67_Serine
Altering_Phenylalanine_67_SerineAltering_Phenylalanine_67_Serine
Altering_Phenylalanine_67_Serine
 
report_mmaillard
report_mmaillardreport_mmaillard
report_mmaillard
 
Schindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASSchindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNAS
 
Venters Molecular and Cellular Biology 2011 2253-2261
Venters Molecular and Cellular Biology 2011 2253-2261Venters Molecular and Cellular Biology 2011 2253-2261
Venters Molecular and Cellular Biology 2011 2253-2261
 
Chloroplast transformation
Chloroplast transformationChloroplast transformation
Chloroplast transformation
 
Lepow Day Poster
Lepow Day PosterLepow Day Poster
Lepow Day Poster
 
Poster Presentation Template
Poster Presentation TemplatePoster Presentation Template
Poster Presentation Template
 
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kd...
 
Final552 (1)
Final552 (1)Final552 (1)
Final552 (1)
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
Cancer Research 2
Cancer Research 2Cancer Research 2
Cancer Research 2
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 

A high copy number screen of the trs23Δ99C mutant

  • 1. QQ AQQ Gabriel Gherman Bendavit Department of Biology Concordia University In the secretion pathway, TRAPP I located in the Cis Golgi) interacts with COPII coated vesicles in the ER-cis Golgi pathway. TRAPP II is located in the trans-Golgi and tether COP I coated vesicles from the early endosome1. Vesicle coated proteins (COP I, COPII and Clathrin) act in vesicle specificity. TRAPP relevance and role in the secretion pathway Introduction TRAPP structure and role in the secretion pathway Screening Methods Results Role of TRS23 C terminal from a GEF Ypt/Rab GTPase study Workflow of the experiment Yeast transformation Mutated TRS23 With High Copy Plasmid Screen status Acknowledgments Mutant strain Supression of mutant Phenotype Conclusion CIN 5 selection The trs23Δ99C haploid S.Cerevisiae (MSY441b strain type α) was transformed by a high copy plasmid (Yep 24) with fragments of a high copy plasmid yeast genomic library (6000 genes) which generated 36000 colonies . The thermic sensitivity phenotype (slow growth at 160C) was suppressed in 37 colonies. A positive control was used with another high copy plasmid (prs 426) with TRS 23 gene on it. Also, a negative control (prs 426 without yeast genomic fragment) was used. Slow growth at 160C (severe) After yeast transformation, colonies were replica plated in three temperatures, permissive (300C), hot (380C) and cold (160C). Using suppression of thermic sensitivity phenotype, 15 colonies were selected to be sequenced. The role of CIN 5 as the agent suppressor of the mutant phenotype is so far not conclusive. Its selection was based in the relationship between TRS 23 and Chromosome instability described by Ben-Aroya 2008. In order to follow up on the study, CIN 5 needs to be isolated and transformed into the trs23Δ99C mutant yeast. The activated form of Ypt/Rab is when (GTP) is bound to Ypt/Rab and its deactivated form is when (GDP) is bound. The elements with GEF activity work by increasing the phosphorylation speed of Ypt/Rab GDP and phosphorylation to its activated form Ypt/Rab GTP. Both TRAPPI/II are GEF for Ypt/Rab GTP ase. Dr. Michael Sacher and all the great scientists from his laboratory, especially to Stephanie Brunet. Confirmation of CIN5 suppression was done by digesting this gene from Yep 24 with Eco R1 and Xho1. The insert was then ligated into the vector prs 426. After bacteria and yeast transformation, the colonies will be evaluated for mutant phenotype suppression. Unfortunately no growth after bacteria transformation was obtained yet. The 37 colonies with mutant phenotype suppressed , selected from the 36,000 transformed yeast colonies, were transformed into E coli (to increase number of copies). The plasmids were then transformed back to yeast (MSY441b) to reevaluate suppression of the phenotype. A selected gene was used in a new round of the screening ( digested from Yep24 and ligated in a new plasmid (prs 426 without TRS23). Slow growth at 380C (mild) After PCR amplification, 15 colonies with mutant suppressed phenotype were sent to be sequenced in three different batches. The six samples that came back as empty vectors will be transformed back into yeast. One failed to be sequenced and an other showed no ORFs. The seven samples with yeast fragments summed a total of 21 genes. From those, CIN5 from Chromosome XV was selected. Membrane trafficking between enclosed cellular compartments use vesicle-mediated transport in order to deliver secretory proteins. One of the components involved in cargo selectivity and proper fusion of vesicles with its specific target membrane are multi-subunit complexes called tethering factors. The transport protein particle (TRAPP) complex is a tethering factor conserved from yeast to man that exists in two types TRAPP I, in the cis Golgi and TRAPP II, in the trans Golgi . TRAPP I has seven subunits and TRAPPII has three extra subunits, they tether COPII and COPI coated protein respectively.2 In yeast both TRAPPI/II are guanine nucleotide exchange factors (GEF) for Ypt1/Rab GTPase which activates it. Ypt1/Rab is responsible for vesicle formation, motility, tethering and fusion of vesicles1. The TRAPP I subunit TRS 23 is a centrally localized essential subunit which is a GEF for YPT1/ RAB GTPase. A study with a C terminal mutated TRS 23 raised some questions regarding this subunit interactions with the TRAPPI complex. Full understanding of TRS 23 function, such as GEF activity for YPT1/ RAB GTPase, is fundamental for the study of the mechanisms involved with the secretion pathway. For this reason a high copy screening of the trs23Δ99C was done. In a previous study3 a triple mutation on C terminal of TRS 23 was found to be deleterious for the cell with a reduction of GEF activity in vitro. TRAPP I complex subunit TRS 23 is centrally localized and together with Bet 5 have a binding site, showed by crystal structure, for Ypt/Rab. However, when a complete C terminal deletion was done at Dr Sacher’s laboratory the cell was still viable. Also, a destabilization in the TRAPP I complex was revealed. This mutation presented thermic sensitivity and this mutant phenotype was used for the screen of Trs23Δ99C . After bacteria transformation by heat shocking or electroporation, the plasmids were extracted and transformed back to yeast for confirmation of mutant phenotype suppression. CIN 5 (from the chromosome XV) encodes for chromosome instability(CIN) and also salt and antibiotic resistance. The CIN 5 selection was based in the association of TRS 23 with CIN. In one study TRS 23 was identified by a screening that used a temperature- sensitive allele for each essential gene in S. cerevisiae. The mutant TRS 23 showed CIN4. CIN 5 Ligation References Spondyloepiphyseal dysplasia tarda (SEDT) is one example of TRAPP importance for human health. This musculoskeletal disorder is associated with TRAPP subunits of its mammalian homolog TRAPPC2. The SNARE complex is responsible for vesicle docking by interaction of two of its subunits t SNARE (in the membrane) and v SNARE ( in the vesicle ). TRAPP I subunit Bet3 binds to the COPII subunit Sec 23 allowing t SNARE and v SNARE to interact1. 1-Sacher M. 2008. Traffic /2- Stephanie Brunet poster 2010 / 3- The cell, fifth edition,chapter 10, figure 10.35 /4-Ben-Aroya 2008,cell Ref. 3Ref. 3 A high copy number screen of the trs23Δ99C mutant Ref 2 C terminus deletion Triple mutation Cells were still viable P X Reduces GEF activity P P Destabilize d TRAPPI P NA XV